Influence of self-injection method against insulin and GLP-1 receptor agonist to blood glucose control and weight change

Influence of self-injection method against insulin and GLP-1 receptor agonist to blood glucose control and weight change - Influence of self-injection method to blood glucose control and weight change

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045065

Enrollment

160

Registered

2021-10-01

Start date

2021-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Over 18 years old 2) Self injection of insulin or GLP-1 receptor agonist for more than 3 months 3) Diabetes mellitus after the diagnosis of more than 3 months 4) The kind of a drug and the device does not matter 5) The patient with an agreement by the free will

Exclusion criteria

Exclusion criteria: 1) The patient who cannot have a medical examination regularly 2) Severe infectious disease, before and after operation, or patient with the serious injury 3) In addition, the target person whom a manager for enforcement judged to be inappropriate as a study subject

Design outcomes

Primary

Measure	Time frame
Confirmation of the self-injection method by the questionary survey	—

Secondary

Measure	Time frame
1) Change of HbA1c and body weight before and after the questionary survey 2) Change of the dose of insulin or GLP-1 receptor agonist 3) Improvement of the injection method using the questionary survey four months later 4) Change of the blood test 5) Correlation with the cognitive function 6) Difference in recording contents and questionnaire result	—

Countries

Japan

Contacts

Public ContactHiroaki Ueno

Faculty of Medicine, University of Miyazaki Division of Hematology, Diabetology and Endocrinology, Department of Internal Medicine

intron@med.miyazaki-u.ac.jp0985-85-9121

Outcome results